ExSight Capital Management

New York, New York
Firm Location:New York, New York
Investor Firms That Co-Invest with ExSight Capital Management
ExSight Capital Management Team
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Robotics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Series A), Investors in Therapeutics (Series A), Investors in Hardware (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Adam Benowitz, Partner at ExSight Capital Management
Adam Benowitz
Sweet spot: $0
Range: $0 - $0
Photo of Randolph Cohen, Partner at ExSight Capital Management
Randolph Cohen
Sweet spot: $0
Range: $0 - $0
Photo of Maneesha Ghiya, Partner at ExSight Capital Management
Maneesha Ghiya
Sweet spot: $0
Range: $0 - $0
MN
Michael Nissen
Sweet spot: $0
Range: $0 - $0
Photo of Firas Rahhal, Partner at ExSight Capital Management
Firas Rahhal
Sweet spot: $0
Range: $0 - $0
Photo of Alan Spiro, Partner at ExSight Capital Management
Alan Spiro
Sweet spot: $0
Range: $0 - $0